All terms in DRUGBANK

Label Id Description
GUANOSINE-2',3'-O-METHYLIDENEPHOSPHONATE DB04757
2s,4r-4-Methylglutamate DB03425
Digalactosyl Diacyl Glycerol (Dgdg) DB03426
2-[(3,5-Dichloro-4-trioxidanylphenyl)amino]benzoic acid DB04756
PROPYL-1-PHOSPHATE DB04755
S-Adenosyl-L-Homoselenocysteine DB03423
Ubenimex DB03424 [Ubenimex (also known as bestatin) is a competitive protease inhibitor. It is an inhibitor of aminopeptidase B, leukotriene A4 hydrolase, aminopeptidase N. It is being studied for use in the treatment of acute myelocytic leukemia.]
GUANOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE DB04754
9-DEAZAINOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE DB04753
2-Phenethyl-2,3-Dihydro-Phthalazine-1,4-Dione DB03421
1,3-Thiazole-4-Carboxylic Acid DB03422
Phosphatidyl ethanol DB04752
Purvalanol A DB04751
2,4-Deoxy-4-Guanidino-5-N-Acetyl-Neuraminic Acid DB03420
OREGON GREEN 488 CARBOXYLATE DB04750
PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE) DB04760
AZD-9977 DB15418 [AZD-9977 is under investigation in clinical trial NCT03843060 (A Phase 1 Study to Assess the Pharmacokinetics of AZD9977 Administered Alone and in Combination With Itraconazole in Healthy Volunteers).]
Recanaclotide DB15417 [Recanaclotide is under investigation in clinical trial NCT01712412 (Phase 2a Study of IW-9179 to Treat Functional Dyspepsia).]
Nanatinostat DB15419 [Nanatinostat is under investigation in clinical trial NCT00697879 (Safety Study of the Histone Deacetylase Inhibitor, CHR-3996, in Patients With Advanced Solid Tumours).]
CM-4307 DB15414 [CM-4307 is under investigation in clinical trial NCT03602495 (Donafenib in 131I-Refractory Differentiated Thyroid Cancer).]